Biologics have significantly advanced the specialty’s options in controlling systemic factors leading to chronic sinus and airway disease. This session will explore the history of biologics, differentiate the biologics currently available, discuss those currently in trials, and present an algorithm for deciding on optimal and efficient usage.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-23297","session","type-session","status-publish","hentry"],"acf":{"status":"Active","airtable_id":"recdJBHe5hXEpxdTO","session_name":"Biologics","session_id":"100","session_code":"ENT100","session_description":"
Biologics have significantly advanced the specialty's options in controlling systemic factors leading to chronic sinus and airway disease. This session will explore the history of biologics, differentiate the biologics currently available, discuss those currently in trials, and present an algorithm for deciding on optimal and efficient usage.<\/p>\n","session_objectives":"1. Define biologics. How are they developed and what is their potential;\n2. Define the pathways leading to various applicable disease states, and show the areas of the pathways affected by biologics;\n3. Enable the practitioner to incorporate most current standards of biologic usage for the appropriate patients;","session_type":"Lunch and Learn","session_type_detail":"Biologics","virtual_content_delivery":"Not Available","onsite_content_delivery":"In-Person","session_delivery_format":"Onsite Only","target_audience_list":["APP Students","APPs","Clinical Staff","Medical Students","Physicians"],"target_audience":"APP Students,APPs,Clinical Staff,Medical Students,Physicians","day":"Saturday","long_start_date":"Saturday, November 6th","start_date":"11\/6\/2021","start_time":"1:15 PM","start_time_timestamp":"1636031700","start_date_timestamp":"1636156800","start_date_and_time_timestamp":"1623417300","end_date":"11\/6\/2021","end_time":"2:00 PM","duration":"1:00","society":"NFO","society_list":["NFO"],"eventcloud_session_id":"","track_name":"ENT","speakers":[{"ID":23390,"post_author":"1","post_date":"2021-11-04 18:56:57","post_date_gmt":"2021-11-04 22:56:57","post_content":"","post_title":"Joseph Han, MD","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"open","post_password":"","post_name":"joseph-han-md","to_ping":"","pinged":"","post_modified":"2021-11-04 18:57:00","post_modified_gmt":"2021-11-04 22:57:00","post_content_filtered":"","post_parent":0,"guid":"http:\/\/fcomnow.com\/speaker\/dr-joseph-han-md\/","menu_order":0,"post_type":"speaker","post_mime_type":"","comment_count":"0","filter":"raw"}],"unique_session":"checked","speaker_location":"Onsite","pre_record":"No","ceu_offered":"No","ceu_hours":"","cme_offered":"Yes","cme_hours":"","tags":["ENT","ENT Surgery","Rhinology","Sinus"],"tags_text":"ENT,ENT Surgery,Rhinology,Sinus","ticketed":"checked","ticketed_session":"checked","ticket_url":"","session_sponsor":{"ID":23542,"post_author":"1","post_date":"2021-11-04 18:54:28","post_date_gmt":"2021-11-04 22:54:28","post_content":"Sanofi is dedicated to supporting patients through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe. Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physicians-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to multiple FDA-approved treatments, almost all of which were homegrown in our laboratories.","post_title":"Sanofi Genzyme & Regeneron","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"open","post_password":"","post_name":"sanofi-genzyme-regeneron","to_ping":"","pinged":"","post_modified":"2021-11-04 18:54:28","post_modified_gmt":"2021-11-04 22:54:28","post_content_filtered":"","post_parent":0,"guid":"http:\/\/fcomnow.com\/sponsor\/sanofi-genzyme-regeneron\/","menu_order":0,"post_type":"sponsor","post_mime_type":"","comment_count":"0","filter":"raw"},"panel_moderator":false,"session_location":"Ritz-Carlton Beach Resort","session_location_room":"Vanderbilt 2"},"day":"Saturday","duration":"1:00","end_date":"11\/6\/2021","end_time":"2:00 PM","session_code":"ENT100","session_description":"Biologics have significantly advanced the specialty's options in controlling systemic factors leading to chronic sinus and airway disease. This session will explore the history of biologics, differentiate the biologics currently available, discuss those currently in trials, and present an algorithm for deciding on optimal and efficient usage.","session_id":"100","session_name":"Biologics","session_objectives":"1. Define biologics. How are they developed and what is their potential;\n2. Define the pathways leading to various applicable disease states, and show the areas of the pathways affected by biologics;\n3. Enable the practitioner to incorporate most current standards of biologic usage for the appropriate patients;","session_type":"Lunch and Learn","session_type_detail":"Biologics","society":"NFO","start_date":"11\/6\/2021","start_time":"1:15 PM","test_speaker_link":[],"yoast_head":"\n